Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2012-03-07

Clinical Trial Update: Testing the Effect of Zinc Supplementation to Improve the Treatment Effect of Botulinum Toxin for Oculofacial Spasm [NA]

View source ↗

Summary

This clinical trial is evaluating whether zinc supplementation improves the effectiveness of botulinum toxin treatment for oculofacial spasm, including blepharo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Botulinum toxin (botulinum toxin)
  • Zinc supplement (zinc)

Snippet

Sponsor: St. Joseph's Healthcare Hamilton | Conditions: Blepharospasm, Hemifacial Spasm | NA | Status: UNKNOWN